These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14304242)

  • 21. [PASSIVE TRANSFER OF IMMUNITY TO TUBERCULOSIS BY MEANS OF CELLS FROM BCG VACCINATED MICE. II. EFFECTS OF VARIOUS PRETREATMENTS OF CELLS TO BE TRANSFERRED].
    ASABA G; NAGATOMI H; WATABIKI S; HUKAZAWA Y; AKIYAMA T; MAEDA K; USHIBA D
    Kekkaku; 1964 Apr; 39():95-9. PubMed ID: 14156231
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tuberculous abscess associated with BCG vaccination].
    GROTH-PETERSEN E
    Ugeskr Laeger; 1952 Oct; 114(42):1503-4. PubMed ID: 13029242
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiple lumps in the breast due to Mycobacterium fortuitum.
    Chandanwale SS; Gulati I; Baravkar DS; Shinde SP; Mishra N
    Indian J Tuberc; 2016 Apr; 63(2):126-9. PubMed ID: 27451824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THE IMMUNOGENICITY OF BCG (PHIPPS) AND ITS ISONIAZID-RESISTANT MUTANT IN GUINEA PIGS SIMULTANEOUSLY VACCINATED, INFECTED, AND TREATED.
    DWORSKI M
    Am Rev Respir Dis; 1964 Jul; 90():97-104. PubMed ID: 14180060
    [No Abstract]   [Full Text] [Related]  

  • 25. A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice.
    Tanghe A; Adnet PY; Gartner T; Huygen K
    Infect Immun; 2007 May; 75(5):2642-4. PubMed ID: 17325046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [EFFECT OF ATTENUATED TUBERCULOUS BACTERIA (BCG) ON NEWBORN RABBITS].
    WEISSFEILER G; FOELDES I; KARASZOVA V
    Tuberk Tudobetegsegek; 1964 Feb; 17():33-5. PubMed ID: 14186502
    [No Abstract]   [Full Text] [Related]  

  • 27. [TUBERCULIN REACTION IN CALFS AFTER VACCINATION WITH BCG VACCINES BOTH SENSITIVE AND RESISTANT TO STREPTOMYCIN AND ISONICOTINIC ACID HYDRAZIDE AND AFTER INFECTION WITH BOVINE BACILLUS DURING INH PREVENTIVE TREATMENT].
    BURACZEWSKI O; OSINSKI J
    Gruzlica (1926); 1964 Sep; 32():773-80. PubMed ID: 14249994
    [No Abstract]   [Full Text] [Related]  

  • 28. [PRIMARY BACTERIAL RESISTANCE].
    IANELLO JA
    Torax; 1963; 12():154-6. PubMed ID: 14158176
    [No Abstract]   [Full Text] [Related]  

  • 29. BCG vaccination and non-tuberculous Mycobacteria.
    Gangadharam PR
    Tubercle; 1981 Sep; 62(3):223-4. PubMed ID: 7314256
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative study of the virulence and protective potency against tuberculous infection of vole bacillus, low-virulent human tubercle bacillus Imamura's strain, and BCG.
    TOSHIMA M
    Sci Rep Res Inst Tohoku Univ Med; 1952 Dec; 4(2):135-49. PubMed ID: 13064629
    [No Abstract]   [Full Text] [Related]  

  • 31. EXPERIMENTAL DRUG STUDIES ON MYCOBACTERIUM FORTUITUM.
    BROSBE EA; SUGIHARA PT; SMITH CR; HYDE L
    Antimicrob Agents Chemother (Bethesda); 1964; 10():733-6. PubMed ID: 14288027
    [No Abstract]   [Full Text] [Related]  

  • 32. A report of iliac muscle abscess due to Mycobacterium bovis after bacillus Calmette-Guerin therapy for bladder cancer.
    Talluri SK; Marigowda L; Besur S; Talluri J; Forstall GJ
    South Med J; 2010 Apr; 103(4):369-70. PubMed ID: 20224496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VACCINATION EXPERIMENTS WITH INH-RESISTANT BCG.
    ENGBAEK HC; JESPERSEN A; RASMUSSEN KN; TOLDERLUNG K
    Acta Tuberc Pneumol Scand Suppl; 1964; 56():SUPPL 56:114-7. PubMed ID: 14160961
    [No Abstract]   [Full Text] [Related]  

  • 34. LYMPH GLAND PROCESSES CAUSED BY ATYPICAL MYCOBACTERIA AND MYCOBACTERIUM AVIUM. BACTERIOLOGICALLY VERIFIED CASES IN DENMARK FROM 1935 TO 1961.
    ENGBAEK HC
    Acta Tuberc Pneumol Scand; 1964; 44():108-37. PubMed ID: 14165365
    [No Abstract]   [Full Text] [Related]  

  • 35. Infection with Mycobacterium kansasii and efficacy of vaccination against tuberculosis.
    Orme IM; Collins FM
    Immunology; 1983 Dec; 50(4):581-6. PubMed ID: 6228515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [VACCINAL POWER IN THE GUINEA PIG OF INH-RESISTANT BCG AND INH-RESISTANT BCG "LABELED" WITH RESISTANCE TO GRAMICIDIN].
    AUGIER J; BRETEY J; AUGIER-GIBORY S; BOISVERT H
    Ann Inst Pasteur (Paris); 1963 Nov; 105():937-48. PubMed ID: 14098103
    [No Abstract]   [Full Text] [Related]  

  • 37. [THE BEHAVIOR OF GUINEA PIGS VACCINATED WITH BCG AND EXPOSED TO NON CLASSIFIED MYCOBACTERIUM INFECTION].
    MELLOGNO MA; CETRANGOLO A
    Rev Asoc Med Argent; 1963 Sep; 77():444-6. PubMed ID: 14091023
    [No Abstract]   [Full Text] [Related]  

  • 38. [CURRENT ASPECTS OF THE PROBLEM OF ANTITUBERCULOUS CONTROL IN FRANCE].
    BERNARD E
    Mars Med; 1964; 101():435-45. PubMed ID: 14136937
    [No Abstract]   [Full Text] [Related]  

  • 39. [Bone tuberculosis of the bovine type after BCG-vaccination (author's transl)].
    Torklus Dv
    Z Orthop Ihre Grenzgeb; 1977 Apr; 115(2):249-52. PubMed ID: 324161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mycobacterium fortuitum infection of ventriculoperitoneal shunt.
    Midani S; Rathore MH
    South Med J; 1999 Jul; 92(7):705-7. PubMed ID: 10414479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.